Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe Publications section was updated to replace the online-ahead-of-print Nat Cancer citation with the finalized Nat Cancer article (SWOG S1512 cohort A) and update its bibliographic details. The update also notes the 2026-03-10 entry date and revision to v3.4.3.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedMinor version update from v3.4.1 to v3.4.2; no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedMinor site-wide updates were made (revision v3.4.1 added and the funding-status notice removed), with no impact on study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedA site-wide funding-status notice was added, and a publication citation related to SWOG S1512 was included.SummaryDifference0.1%

- Check50 days agoChange DetectedShow glossary option has been added and the page now displays updated metadata labels, including Last Update Submitted that Met QC Criteria and Last Update Posted, plus Revision: v3.4.0. The older QC-related labels and the previous revision reference (Revision: v3.3.4) were removed.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.